Matches in Wikidata for { <http://www.wikidata.org/entity/Q79405831> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q79405831 description "artículu científicu espublizáu n'avientu de 2006" @default.
- Q79405831 description "im Dezember 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q79405831 description "scientific article published on 05 December 2006" @default.
- Q79405831 description "wetenschappelijk artikel" @default.
- Q79405831 description "наукова стаття, опублікована в грудні 2006" @default.
- Q79405831 name "Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin" @default.
- Q79405831 name "Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin" @default.
- Q79405831 type Item @default.
- Q79405831 label "Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin" @default.
- Q79405831 label "Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin" @default.
- Q79405831 prefLabel "Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin" @default.
- Q79405831 prefLabel "Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin" @default.
- Q79405831 P1433 Q79405831-6FB629E3-D078-498F-9A34-14D9FD9B649B @default.
- Q79405831 P1476 Q79405831-92F87385-BF08-4A96-ACDF-57F58B1E930E @default.
- Q79405831 P2093 Q79405831-4DD6135A-37BD-450D-BACE-AB2DD57AD973 @default.
- Q79405831 P2093 Q79405831-85E75FBE-7C8D-497C-99B2-2F31560914AB @default.
- Q79405831 P2093 Q79405831-879968E2-A3D0-4F34-98F5-7D2FD7D9D623 @default.
- Q79405831 P2093 Q79405831-FB9A0287-C15C-4B2A-A6DB-C2B34B48E3BB @default.
- Q79405831 P304 Q79405831-C0A74879-A44D-4C8E-AE50-544DFF7D831F @default.
- Q79405831 P31 Q79405831-7ACAF993-31C9-42E8-9837-A4AA517D84FA @default.
- Q79405831 P356 Q79405831-CED1F3B4-3C73-4964-AF08-E2BB7FB3F416 @default.
- Q79405831 P433 Q79405831-61027091-21B0-4DC3-98EB-52334DC07C0A @default.
- Q79405831 P478 Q79405831-AAEB5AE8-30E2-489C-9F89-41BF8FE7DCA8 @default.
- Q79405831 P50 Q79405831-466E01D8-5E80-4AC6-B9C1-6EDD8815BC24 @default.
- Q79405831 P50 Q79405831-6B5D7333-6E47-4B9E-8FE1-9ADD481C46F1 @default.
- Q79405831 P50 Q79405831-7CF8F26D-B419-49BB-BB2E-41EE8C202918 @default.
- Q79405831 P577 Q79405831-CE4F85C5-04DE-44DE-9F39-4760CE971F41 @default.
- Q79405831 P698 Q79405831-421AF54A-A70E-474C-8A03-B9366C4E37DD @default.
- Q79405831 P921 Q79405831-D23CFC49-3309-4B1A-9A20-8F8E9E1F1A5B @default.
- Q79405831 P921 Q79405831-E0F472FD-0AAE-418E-B898-D506F93F9962 @default.
- Q79405831 P356 S00277-006-0220-3 @default.
- Q79405831 P698 17146676 @default.
- Q79405831 P1433 Q15766509 @default.
- Q79405831 P1476 "Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin" @default.
- Q79405831 P2093 "Dominic T Moore" @default.
- Q79405831 P2093 "Mary Jo Lehman" @default.
- Q79405831 P2093 "Peter M Voorhees" @default.
- Q79405831 P2093 "Suzanne E Biehn" @default.
- Q79405831 P304 "211-216" @default.
- Q79405831 P31 Q13442814 @default.
- Q79405831 P356 "10.1007/S00277-006-0220-3" @default.
- Q79405831 P433 "3" @default.
- Q79405831 P478 "86" @default.
- Q79405831 P50 Q109984365 @default.
- Q79405831 P50 Q91428664 @default.
- Q79405831 P50 Q91807421 @default.
- Q79405831 P577 "2006-12-05T00:00:00Z" @default.
- Q79405831 P698 "17146676" @default.
- Q79405831 P921 Q18936 @default.
- Q79405831 P921 Q467635 @default.